<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="ted/R2.0.8.S03/publication" xmlns:n2016="ted/2016/nuts" xsi:schemaLocation="ted/R2.0.8.S03/publication TED_EXPORT.xsd" DOC_ID="057736-2018" EDITION="2018026"><TECHNICAL_SECTION><RECEPTION_ID>18-055644-001</RECEPTION_ID><DELETION_DATE>20180516</DELETION_DATE><FORM_LG_LIST>ES </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple " xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>26</NO_OJ><DATE_PUB>20180207</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2018/S 026-057736</NO_DOC_OJS><URI_LIST><URI_DOC LG="ES">http://ted.europa.eu/udl?uri=TED:NOTICE:057736-2018:TEXT:ES:HTML</URI_DOC></URI_LIST><LG_ORIG>ES</LG_ORIG><ISO_COUNTRY VALUE="ES"/><IA_URL_GENERAL>http://www.juntadeandalucia.es/servicioandaluzdesalud</IA_URL_GENERAL><ORIGINAL_CPV CODE="33651610">Diphtheria-pertussis-tetanus vaccines</ORIGINAL_CPV><n2016:PERFORMANCE_NUTS CODE="ES618">Sevilla</n2016:PERFORMANCE_NUTS><VALUES_LIST><VALUES TYPE="GLOBAL"><SINGLE_VALUE><VALUE CURRENCY="EUR">7 848 750,00</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="EUR">7 848 750,00</VALUE></SINGLE_VALUE></VALUES></VALUES_LIST><REF_NOTICE><NO_DOC_OJS>2017/S 150-310040</NO_DOC_OJS></REF_NOTICE></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20180205</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="1">Open procedure</PR_PROC><RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="Z">Not specified</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01203</HEADING><DIRECTIVE VALUE="2004/18/EC"/></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Иcпaния</TI_CY><TI_TOWN>Севиля</TI_TOWN><TI_TEXT>Ваксини против дифтерит, коклюш и тетанус</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Španělsko</TI_CY><TI_TOWN>Sevilla</TI_TOWN><TI_TEXT>Očkovací látka proti záškrtu, tetanu a dávivému kašli</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Spanien</TI_CY><TI_TOWN>Sevilla</TI_TOWN><TI_TEXT>Difteri-pertussis-tetanus vacciner</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Spanien</TI_CY><TI_TOWN>Sevilla</TI_TOWN><TI_TEXT>Diphtherie-Pertussis-Tetanus-Impfstoffe (DPT)</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Ισπανία</TI_CY><TI_TOWN>Σεβίλη</TI_TOWN><TI_TEXT>Εμβόλια διφθερίτιδας-τετάνου-κοκκύτη</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Spain</TI_CY><TI_TOWN>Seville</TI_TOWN><TI_TEXT>Diphtheria-pertussis-tetanus vaccines</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>España</TI_CY><TI_TOWN>Sevilla</TI_TOWN><TI_TEXT>Vacunas contra la difteria, el tétanos y la tos ferina</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Hispaania</TI_CY><TI_TOWN>Sevilla</TI_TOWN><TI_TEXT>Difteeria-läkaköha-teetanuse vaktsiinid</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Espanja</TI_CY><TI_TOWN>Sevilla</TI_TOWN><TI_TEXT>Difteria-, pertussis- ja tetanusrokotteet</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Espagne</TI_CY><TI_TOWN>Séville</TI_TOWN><TI_TEXT>Vaccins antidiphtérie, anticoqueluche et antitétanos</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Spáinn, an</TI_CY><TI_TOWN>Sevilla</TI_TOWN><TI_TEXT>Diphtheria-pertussis-tetanus vaccines</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Španjolska</TI_CY><TI_TOWN>Sevilla</TI_TOWN><TI_TEXT>Cjepiva protiv difterije-pertusisa-tetanusa</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Spanyolország</TI_CY><TI_TOWN>Sevilla</TI_TOWN><TI_TEXT>Diftéria-szamárköhögés-tetanusz vakcinák</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Spagna</TI_CY><TI_TOWN>Siviglia</TI_TOWN><TI_TEXT>Vaccini DTP (difteria-tetano-pertosse)</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Ispanija</TI_CY><TI_TOWN>Sevilija</TI_TOWN><TI_TEXT>Difterijos-kokliušo-stabligės vakcinos</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Spānija</TI_CY><TI_TOWN>Seviļa</TI_TOWN><TI_TEXT>Kombinētas difterijas, garā klepus un tetanusa vakcīnas</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>Spanja</TI_CY><TI_TOWN>Sevilla</TI_TOWN><TI_TEXT>Vaċċini tad-difterja-pertussis-tetanus</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Spanje</TI_CY><TI_TOWN>Sevilla</TI_TOWN><TI_TEXT>DPT-vaccins</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Hiszpania</TI_CY><TI_TOWN>Sewilla</TI_TOWN><TI_TEXT>Szczepionki przeciw dyfterytowi-kokluszowi-tężcowi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Espanha</TI_CY><TI_TOWN>Sevilha</TI_TOWN><TI_TEXT>Vacinas contra a difteria, tosse convulsa e tétano</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Spania</TI_CY><TI_TOWN>Sevilla</TI_TOWN><TI_TEXT>Vaccinuri împotriva difteriei, antitusive şi antitetanos</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Španielsko</TI_CY><TI_TOWN>Sevilla</TI_TOWN><TI_TEXT>Očkovacie látky proti záškrtu, čiernemu kašľu a tetanu</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Španija</TI_CY><TI_TOWN>Sevilja</TI_TOWN><TI_TEXT>Cepiva proti davici-oslovskemu kašlju-tetanusu</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Spanien</TI_CY><TI_TOWN>Sevilla</TI_TOWN><TI_TEXT>Vacciner mot difteri, kikhosta och stelkramp</TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="ES">Servicio Andaluz de Salud. Servicios Centrales</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><CONTRACT_AWARD CATEGORY="ORIGINAL" FORM="3" LG="ES" VERSION="R2.0.8.S03.E01"><FD_CONTRACT_AWARD CTYPE="SUPPLIES"><CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><CA_CE_CONCESSIONAIRE_PROFILE><ORGANISATION><OFFICIALNAME>Servicio Andaluz de Salud. Servicios Centrales</OFFICIALNAME></ORGANISATION><ADDRESS>Avenida de la Constitución, 18</ADDRESS><TOWN>Sevilla</TOWN><POSTAL_CODE>41071</POSTAL_CODE><COUNTRY VALUE="ES"/><CONTACT_POINT>Subdirección de Compras y Logística</CONTACT_POINT><PHONE>+34 955018113</PHONE><FAX>+34 955018048</FAX></CA_CE_CONCESSIONAIRE_PROFILE><INTERNET_ADDRESSES_CONTRACT_AWARD><URL_GENERAL>http://www.juntadeandalucia.es/servicioandaluzdesalud</URL_GENERAL></INTERNET_ADDRESSES_CONTRACT_AWARD></NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF><TYPE_AND_ACTIVITIES><TYPE_OF_CONTRACTING_AUTHORITY VALUE="BODY_PUBLIC"/><TYPE_OF_ACTIVITY VALUE="HEALTH"/></TYPE_AND_ACTIVITIES><PURCHASING_ON_BEHALF><PURCHASING_ON_BEHALF_NO/></PURCHASING_ON_BEHALF></TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF></CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><DESCRIPTION_AWARD_NOTICE_INFORMATION><TITLE_CONTRACT><P>CCA. 6XCBHD6. Contrato de Suministros</P></TITLE_CONTRACT><TYPE_CONTRACT_LOCATION_W_PUB><TYPE_CONTRACT VALUE="SUPPLIES"/><TYPE_SUPPLIES_CONTRACT VALUE="PURCHASE"/></TYPE_CONTRACT_LOCATION_W_PUB><LOCATION_NUTS><n2016:NUTS CODE="ES618"/></LOCATION_NUTS><SHORT_CONTRACT_DESCRIPTION><P>Suministro de vacuna combinada frente a difteria, tétanos y tosferina acelular de contenido antigénico reducido(dTpa) para el Programa de Vacunación Andaluz (PVA).</P></SHORT_CONTRACT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33651610"/></CPV_MAIN></CPV><CONTRACT_COVERED_GPA VALUE="YES"/></DESCRIPTION_AWARD_NOTICE_INFORMATION><TOTAL_FINAL_VALUE><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="7848750.00">7 848 750,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></TOTAL_FINAL_VALUE></OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><TYPE_OF_PROCEDURE_DEF><PT_OPEN/></TYPE_OF_PROCEDURE_DEF><AWARD_CRITERIA_CONTRACT_AWARD_NOTICE_INFORMATION><F03_IS_ELECTRONIC_AUCTION_USABLE VALUE="NO"/></AWARD_CRITERIA_CONTRACT_AWARD_NOTICE_INFORMATION><ADMINISTRATIVE_INFORMATION_CONTRACT_AWARD><FILE_REFERENCE_NUMBER><P>CCA. 6XCBHD6 (2017/071756)</P></FILE_REFERENCE_NUMBER><PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F3><PREVIOUS_PUBLICATION_EXISTS_F3><CNT_NOTICE_INFORMATION><CNT_NOTICE_INFORMATION_S CHOICE="CONTRACT_NOTICE"/><NOTICE_NUMBER_OJ>2017/S 150-310040</NOTICE_NUMBER_OJ><DATE_OJ><DAY>08</DAY><MONTH>08</MONTH><YEAR>2017</YEAR></DATE_OJ></CNT_NOTICE_INFORMATION><NO_OTHER_PREVIOUS_PUBLICATION/></PREVIOUS_PUBLICATION_EXISTS_F3></PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F3></ADMINISTRATIVE_INFORMATION_CONTRACT_AWARD></PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><AWARD_OF_CONTRACT><CONTRACT_NUMBER>1</CONTRACT_NUMBER><CONTRACT_AWARD_DATE><DAY>05</DAY><MONTH>12</MONTH><YEAR>2017</YEAR></CONTRACT_AWARD_DATE><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Glaxosmithkline, S.A.</OFFICIALNAME></ORGANISATION></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="7848750.00">7 848 750,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><COMPLEMENTARY_INFORMATION_CONTRACT_AWARD><RELATES_TO_EU_PROJECT_NO/><NOTICE_DISPATCH_DATE><DAY>05</DAY><MONTH>02</MONTH><YEAR>2018</YEAR></NOTICE_DISPATCH_DATE></COMPLEMENTARY_INFORMATION_CONTRACT_AWARD></FD_CONTRACT_AWARD></CONTRACT_AWARD></FORM_SECTION></TED_EXPORT>